Evidence map›Paper›PMID 30159358›Full record

ArticleInternational journal of particle therapy2018

Investigating Dependencies of Relative Biological Effectiveness for Proton Therapy in Cancer Cells.

Michelle E Howard, Chris Beltran, Sarah Anderson, Wan Chan Tseung, Jann N Sarkaria, Michael G Herman

Abstract read
In one paragraph

Article in International journal of particle therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. A High-Precision Method for In Vitro Proton Irradiation.International journal of particle therapy · 2020
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michelle E HowardDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Chris BeltranDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Sarah AndersonDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Wan Chan TseungDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Jann N SarkariaDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Michael G HermanDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.

Funding

Interdisciplinary Training in Lung Physiology and Biomedical EngineeringT32HL105355 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2012 to 2021
$3.9M
NHLBI NIH HHS T32 HL105355
6 · The paper itself

Abstract

purposeRelative biological effectiveness (RBE) accounts for the differences in biological effect from different radiation types. The RBE for proton therapy remains uncertain, as it has been shown to vary from the clinically used value of 1.1. In this work we investigated the RBE of protons and correlated the biological differences with the underlying physical quantities. MATERIALS AND

methodsThree cell lines were irradiated (CHO, Chinese hamster ovary; A549, human lung adenocarcinoma; and T98, human glioma) and assessed for cell survival by using clonogenic assay. Cells were irradiated with 71- and 160-MeV protons at depths along the Bragg curve and 6-MV photons to various doses. The dose-averaged lineal energy (

resultsProton RBE values ranged from 0.89 to 2.40. The RBE for all 3 cell lines increased with decreasing proton energy and was higher at 50% survival than at 10% survival. Additionally, both A549 and T98 cells generally had higher RBE values relative to the CHO cells, indicating a greater biological response to protons. An increase in RBE corresponded with an increase in

conclusionProton RBE was found to depend on mean proton energy, survival end point, and cell type. Changes in both

Indexed as

lineal energyproton therapyrelative biological effectiveness (RBE)

Identifiers

PMID30159358
PMCPMC6110616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.